Tamfinder market filing
Europe (EU)
Jul 16, 2026
AI ocpilot for founder meantal health
TAM // TOTAL ADDRESSABLE MARKET
SAM // SERVICEABLE ADDRESSABLE MARKET
Low confidence€4.1M to €12M
SOM 3YR // SERVICEABLE OBTAINABLE MARKET
The buyer pool is too thin and too stigmatized to reach venture scale
Your TAM tops out at roughly €41M even under generous scope assumptions, and the SAM collapses to under €1M once you apply realistic adoption rates to a founder population that, by the evidence, numbers only 26,000 new entrants per year across all of Europe. The weakest link in any pitch here is the conversion assumption: corporate wellness programs struggle to hit 20% adoption among employees who have HR nudging them; self-selecting founders with stigma around disclosing mental health challenges will convert at a fraction of that. Woebot's 2025 shutdown is the sharpest cautionary data point. Lyra Health at a $5.58B valuation targets large employer contracts, not individual founders, so the segment is not crowded, it is simply too small to matter at venture scale.
Key risk
26,000 addressable founders per year in Europe cannot support venture returns at any credible conversion rate.
TAM // TOTAL ADDRESSABLE MARKET
€41M
EU mental health software market is €410M in 2025; founder-specific AI copilot is roughly 10% of that scope, yielding ~€41M top-down.
SAM // SERVICEABLE ADDRESSABLE MARKET
Low confidence€4.1M to €12M
stated: €8.2M
20% of TAM reachable: SaaS-native founders in DE, FR, NL willing to pay for a non-clinical AI tool; excludes regulated clinical segments and non-English markets.
Top-down filter (20% of €41M TAM) yields €8.2M; bottom-up (2,600 paying founders at €264/yr) yields €690K, a 12x gap driven by the unknown adoption rate assumption.
SOM 3YR // SERVICEABLE OBTAINABLE MARKET
€690K
Year 3 capture of roughly 2,600 paying founders at €264/yr annual plan; assumes 0.
>Methodology
TAM TOP-DOWN
EU mental health software market is €410M in 2025 per MarketDataForecast. The full market covers clinical tools, teletherapy, patient monitoring, and enterprise EAPs. An AI copilot aimed at founders is a non-clinical, B2C or B2SMB SaaS product. Conservatively, this sub-segment represents 10% of the broader market, excluding regulated clinical and hospital-procurement spend.
€410M EU mental health software (2025) x 10% non-clinical SaaS sub-segment = €41M TAM
TAM BOTTOM-UP
Europe produces roughly 26,000 new registered startups per year per Glassdollar/Crunchbase estimate. Assuming two co-founders per startup gives 52,000 addressable founder-individuals. Using Copilotly's Pro Plan of $29/month (~€264/year) as the pricing proxy (the only founder-adjacent AI mental health price found), and a 5% willingness-to-pay rate drawn from the low end of corporate wellness adoption benchmarks cited in evidence.
52,000 founders x 5% WTP x €264/yr = €686K annual; scale to 5-year cohort stock (x5) = ~€3.4M; round to €35M at 10x revenue multiple for TAM comparison context, but raw annual revenue pool = €3.4M
SAM FILTERS
Lead countries: Germany (21.3% EU mental health software share), France, Netherlands (strong SaaS adoption, English fluency). Filter 1: SaaS-native founders only, ~50% of total (removes offline SMB owners). Filter 2: English or German product reach, ~60% of filtered pool. Filter 3: non-clinical positioning to sidestep EU AI Act high-risk classification, removing ~33% of clinical-adjacent use cases. Combined filter: 20% of TAM.
€41M TAM x 50% SaaS-native x 60% language reach x 67% non-clinical = ~€8.2M SAM
SOM BUILD
A competent new entrant in year 1 realistically signs 200 paying founders (0.04% of 26,000 annual cohort) at €264/yr = €53K. Year 2: 800 founders = €211K. Year 3: 2,600 founders = €686K, representing 0.5% of annual new-startup cohort. GDPR compliance costs, stigma barriers, and Woebot's 2025 shutdown all suppress the ramp. 3-year cumulative SOM is approximately €950K; year-3 run rate is used as the SOM display figure.
2,600 founders x €264/yr = €686K year-3 run rate; 3-year cumulative = 200+800+2,600 x €264 = ~€950K
Competitors // Threat map
| Name | Funding | Positioning | Threat |
|---|---|---|---|
| Lyra Health | $915M raised, $5.58B valuation (2022) | AI-powered mental health benefits platform sold to large employers; 2M+ covered members | Low direct threat: targets HR buyers at large corporates, not founders. Indirect threat: sets market expectation that mental health AI is an employer benefit, not a personal subscription. |
| Wysa | $30.5M raised; 2024 revenue $4.68M | AI chatbot for mental health support, B2B2C via employers and insurers | Medium: already in EU markets, clinically validated, cheaper to integrate than building new. Its $4.68M revenue after years of operation shows how hard monetization is in this category. |
| Headspace (Ebb AI) | Headspace raised $215M+ historically; Ebb is an internal product line | Evidence-based coaching and mindfulness platform with clinical oversight, sold to employers and consumers | Medium: brand recognition and clinical credibility are strong; a founder-specific niche is not their focus, but their consumer app already competes for the same user attention. |
| Woebot Health | Raised undisclosed rounds; shut down 2025 | Chat-based AI therapy tool founded by Stanford clinical psychologist; mission-driven accessibility play | Informational threat: its 2025 shutdown after clinical validation and meaningful funding is the single strongest cautionary signal for this category, pointing to regulatory and commercialization ceiling. |
Sources
- 01Europe Mental Health Software Market, MarketDataForecast · TAM top-down base figure (€410M in 2025), CAGR, Germany market share
- 02Estimating the Number of Startups in Europe, Glassdollar/Medium · Bottom-up customer count: 26,000 new EU startups per year
- 03Copilotly Mental Health Copilot Pricing · Pricing anchor: $29/month (~€264/year) for AI mental health copilot Pro Plan
- 04Lyra Health Financials, Tracxn · Competitor funding and valuation benchmark
- 05Wysa Financials, Tracxn · Competitor funding and revenue; calibrates realistic monetization ceiling
- 06Woebot Health Shutdown, Skywork AI · Key headwind: category-level commercialization failure signal
- 07GDPR Mental Health AI Compliance, Mannsetu · Regulatory headwind: GDPR special-category data and EU AI Act burden
- 08European Startups by Country, GreyB · Lead country identification and founder population by country
- 09AI-Powered Mental Health Solution Market, Emergen Research · Europe share of global AI mental health market (28.5%) for scope context
- 10Europe Chatbot Mental Health Apps CAGR, GlobeNewswire · Sub-market CAGR (16.2%) and UK/Germany lead market shares
More filings
Size another idea